Description

Nemotan (nimodipine) Coated Tablets 30 mg. №100

Ingredients

Each coated tablet contains 30 mg of nimodipine as the active ingredient.

Dosage

The usual dose is 60 mg (2 tablets) every 4 hours, totaling 360 mg per day.

Indications

Nemotan (nimodipine) is indicated for the improvement of neurological outcome by reducing the severity of neurological deficits due to subarachnoid hemorrhage.

Contraindications

Do not use Nemotan if you are allergic to nimodipine or any other ingredients in the product.

Directions

Swallow the tablets whole with a full glass of water. Do not crush or chew the tablets.

Scientific Evidence

Nimodipine, the active ingredient in Nemotan tablets, is a calcium channel blocker that specifically acts on cerebral blood vessels. By blocking calcium influx into smooth muscle cells, nimodipine dilates cerebral arteries, increasing blood flow to the brain. This mechanism is crucial in the treatment of subarachnoid hemorrhage, where vasospasm can lead to poor neurological outcomes.

Additional Information

Nemotan (nimodipine) has been extensively studied in clinical trials for its efficacy in improving outcomes post-subarachnoid hemorrhage. Research has shown that nimodipine significantly reduces the incidence of delayed cerebral ischemia and improves neurological outcomes in patients with aneurysmal subarachnoid hemorrhage.

Compared to other calcium channel blockers, nimodipine has a higher affinity for cerebral blood vessels, making it a preferred choice for the prevention of vasospasm and its associated complications in subarachnoid hemorrhage patients.